stereotactic ablative radiotherapySABRimmunotherapyNSCLCnon-small cell lung cancerSTARS trial
…improved event-free survival (EFS) when adding immunotherapy to stereotactic ablative radiotherapy (SABR) for early-stage inoperable non-small cell lung cancer (N…